Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07480525Not ApplicableNot Yet Recruiting

Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder

Role: collaborator

NCT06685861Not ApplicableActive Not Recruiting

Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression

Role: collaborator

NCT06255535Not ApplicableRecruiting

pBFS Guided rTMS Over Cognitive Control Network for ASD

Role: collaborator

All 3 trials loaded